Prevention of recurrent Reis-Bücklers dystrophy following excimer laser phototherapeutic keratectomy with topical mitomycin C

Cornea

Volumn 23, Issue 7, 2004, Pages 732-735

  Miller, Andrew ^a   Solomon, Renée ^b   Bloom, Adam ^b   Palmer, Carrie ^b   Perry, Henry D ^b   Donnenfeld, Eric D ^a,b  

^a EAR AND THROAT HOSPITAL   (United States)

^b OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

Author keywords

Corneal dystrophy; Mitomycin C; Phototherapeutic keratectomy; Reis B cklers dystrophy

Indexed keywords

MITOMYCIN C;

AGED; BEST CORRECTED VISUAL ACUITY; CASE REPORT; CORNEA DYSTROPHY; DRUG SAFETY; EXCIMER LASER; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; KERATECTOMY; PHOTOTHERAPEUTIC KERATECTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; REIS BUCKLERS DYSTROPHY; REVIEW; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; AGED; ALKYLATING AGENTS; CHEMOTHERAPY, ADJUVANT; CORNEAL DYSTROPHIES, HEREDITARY; FEMALE; HUMANS; INTRAOPERATIVE CARE; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; MITOMYCIN; RECURRENCE;

EID: 4744364749     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000127476.37175.6d     Document Type: Review

References (25)

1. Waring GO 3rd, Rodrigues MM, Laibson PR. Corneal dystrophies. I. Dystrophies of the epithelium, Bowman's layer and stroma. Surv Ophthalmol. 1978;23:71-122.
2. Perry HD, Fine BS, Caldwell DR. Reis-Bucklers dystrophy: a study of eight cases. Arch Ophthalmol. 1979;97:664-670.
3. Stark WJ, Chamon W, Kamp MT, et al. Clinical follow-up of 193-nm ArF excimer laser photokeratectomy. Ophthalmology. 1992;99:805-812.
4. Dinh R, Rapuano CJ, Cohen EJ, et al. Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology. 1999; 106:1490-1497.
5. Crooke ST, Bradner WT. Mitomycin C: a review. Cancer Treat Rev. 1976;3:121-139.
6. Talamo JH, Gollamudi S, Green WR, et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol. 1991;109:1141-1146.
7. Schipper I, Suppelt C, Gebbers JO. Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits. Eye. 1997;11:649-655.
8. Majmudar PA, Forstot SL, Dennis RF, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology. 2000;107:89-94.
9. Marcon AS, Rapuano CJ. Excimer laser phototherapeutic keratectomy retreatment of anterior basement membrane dystrophy and Salzmann's nodular degeneration with topical mitomycin C. Cornea. 2002;21:828-830.
10. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98:317-321.
11. Mahar PS, Nwokora GE. Role of mitomycin C in pterygium surgery. Br J Ophthalmol. 1993;77:433-435.
12. Kraut A, Drnovsek-Olup B. Instillation of mitomycin C after recurrent pterygium surgery. Eur J Ophthalmol. 1996;6:264-267.
13. Helal M, Messiha N, Amayem A, et al. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium. Ophthalmic Surg Lasers. 1996;27:674-678.
14. Donnenfeld ED, Perry HD, Fromer S, et al. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision. Ophthalmology. 2003; 110:1012-1016.
15. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology. 1988;95:813-821.
16. Frucht-Pery J, Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology. 1994;101:759-762.
17. Heigle TJ, Shilling RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol. 1997; 124:397-399.
18. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997;124:303-311.
19. Donnenfeld ED, Perry HD, Wallerstein A, et al. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology. 1999;106:72-78; discussion 79.
20. Heitzmann J, Binder PS, Kassar BS, et al. The correction of high myopia using the excimer laser. Arch Ophthalmol. 1993;111:1627-1634.
21. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99: 1647-1654.
22. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea. 1996;15:537-540.
23. Safianik B, Ben-Zion I, Garzozi HJ. Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol. 2002;86: 357-358.
24. Tsai YY, Lin JM, Shy JD. Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea. 2002;21:227-229.
25. Carones F, Vigo L, Scandola E, et al. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg. 2002;28:2088-2095.